• Journal of Yeungnam Medical Science
• /
• 제31권1호
• /
• pp.52-55
• /
• 2014

Protein S deficiency is one of the several risk factors for thrombophilia and can cause blood clotting disorders such as deep vein thrombosis and pulmonary embolism. A 54-year-old man was admitted with the complaint of dyspnea and was diagnosed with pulmonary embolism. The patient had very low level of free protein S, total protein S antigen, and protein S activity (type I protein S deficiency). In history taking, we found that his mother, 78 year old, had a history of same disease 10 years ago, and confirmed the pronounced low level of protein S. The patient's son also had very low level of protein S, however there had not been any history of pulmonary embolism yet. This case study suggests that asymptomatic persons with a family history of protein S deficiency and pulmonary embolism should be checked regularly for early detection of the disease, as protein S deficiency can be suspected.

• Asian Pacific Journal of Cancer Prevention
• /
• 제13권7호
• /
• pp.3191-3194
• /
• 2012

Objective: To investigate the association between the change of IGF-2 level in serum after transcatheter arterial chemoembolization (TACE) and hepatocellular carcinoma (HCC) progression, especially in relation to metastasis. Methods: IGF-2 in serum was measured by quantitative sandwich enzyme-linked immunosorbent assaybefore, 3 days and 4 weeks after TACE in 60 patients with HCC. The occurrence of HCC metastasis was also evaluated, 3 months after TACE. Results: (1) The average serum level of IGF-2 in the 60 patients with HCC was $136.5{\pm}87.3$ pg/ml; (2) A tendency for increase was observed with heterogenous uptake of octreotide and portal vein thrombosis. Metastatic foci were found in 37/38 patients in the group with IGF-2 increasing (97.0%), in contrast to 3/22 (13.6%) patients with IGF-2 decrease. Conclusion: The increase of IGF-2 level in serum appears to be associated with the occurrence of metastatic HCC after TACE and chemotherapy.

• 혜화의학회지
• /
• 제4권2호
• /
• pp.91-103
• /
• 1996

This study was performed to prove the clinical effects of Kyejibokryoung hwan(KBH), Jeodangtang(JDT), Kyejibokryounghwan & Jeo-dangtang(KJT) by way of experimental methods. The intravascular coagulation was induced by injection of endotoxin into the caudal vein of rats. And liquid extracts of Kyejibokryounghwan, Jeodangtang, Kyejibokryounghwan & Jeodang- tang were administerd orally to the rats. Then the number of platelets, concentration of fibrinogen, FDP(fibrin-fibrinogen degradation products), prothrombin time and PTT(partial thromboplastin time) were measured. The results were obtained as follows ; 1. The number of platelets was significantly increased in KBH and KJT-treated groups in comparison with the control group. 2. Fibrinogen was significantly increased in all sample groups as compared with the control group. 3. FDP was insignificantly decreased in all sample groups but have not significant. 4. Prothrombin time was significantly shortened in JDT and KJT-treated groups as compared with the control group. 5. PTT was significantly shortened in only KJT -treated groups as compared with the control group. From the above results, it was concluded that Kyejibokryounghwan, Jeodang tang, Kyejibokryounghwan & Jeodangtang can be applied effectively in the disease of thrombosis.

• 중환자간호학회지
• /
• 제10권2호
• /
• pp.14-23
• /
• 2017

Purpose: The purpose of this study was to evaluate the effectiveness of a ventilator-associated pneumonia (VAP) bundle. Methods: This was a retrospective study that was carried out between June 2010 and October 2015. In this study, 3,224 intubated patients were included. The VAP bundle which was applied to Group 1 patients (n=470) included head-of-bed elevation to 30 degrees, cuff pressure monitorization, prophylaxis of peptic ulcer, and prophylaxis of deep vein thrombosis. The VAP bundle for Group 2 patients (n=1,914) included all the elements of the VAP bundle for Group 1 patients and one additional element which was oral care with 0.12% chlorhexidine. The VAP bundle for Group 3 patients (n=870) added sedative interruption and assessment of readiness to extubate to the VAP bundle for Group 2. Results: The numbers and incidences of VAP were significantly different among the three groups. Moreover, there were significant differences among groups in ICU length of stay and mortality. Conclusion: Three different VAP prevention bundles made different effects in patient outcomes.

• 대한족부족관절학회지
• /
• 제16권3호
• /
• pp.181-189
• /
• 2012

Purpose: The purpose of this study was to compare and analyse the clinical outcomes of minimal incision repair and open repair in ruptured Achilles tendon. Materials and Methods: We retrospectively analyzed the outcomes of 10 patients with minimal incision repair (group 1) and 19 patients with open repair (group 2) from February 2007 to June 2011. The postoperative clinical evaluations were done by Arner-Lindholm scale, AOFAS score, overall patient's satisfaction and cosmetic satisfaction of scar. Results: There was no statistical difference between two groups in Arner-Lindholm scale, AOFAS score, overall patient's satisfaction (p=1.21, 0.87, 1.07). There was statistically high rate of cosmetic satisfaction in group 1(p<0.001). There were no complications in group 1. Complications occurred in three patients (deep infection, rerupture, deep vein thrombosis) of group 2. Conclusion: Treatment of minimal incision repair in Achilles's tendon ruptures showed high rate of cosmetic satisfaction and low rate of complication's, but there were no significant differences with open repair in other clinical outcomes. The minimal incision repair could be recommended as one of the effective treatment for the Achilles's tendon ruptures.

• Journal of Chest Surgery
• /
• 제40권6호
• /
• pp.463-466
• /
• 2007

21세 남자 환자가 우측 손의 통증, 부종 및 저린감을 주소로 내원하였다. 정맥 조영술 및 MRI scan으로 Paget-Schroetter syndrome으로 진단되었으며, 혈전 용해술을 시행하였으나 호전이 없어 흉강경하에 1번 늑골 절제술을 시행하였다. 환자는 수술 후 증상이 호전되었으며, warfarin 처방과 함께 퇴원하였다. 통상적으로 알려진 1번 늑골 절제법은 경액와 접근법(transaxillary) 혹은 쇄골상부 접근법(supra-clavivular)등이 있으나, 본 증례의 경우 흉강경하에 1번 늑골 절제술을 시행하였고 이에 결과를 보고하는 바이다.

• Journal of Chest Surgery
• /
• 제44권5호
• /
• pp.377-379
• /
• 2011

Chylopericardium is a rare disease entity characterized by the accumulation of chylous fluid in the pericardial sac. It usually arises from mediastinal neoplasms, thrombosis of the subclavian vein, tuberculosis, nonsurgical trauma, thoracic or cardiac surgery. The spectrum of symptoms for chylopericardium varies from an incidental finding of cardiomegaly to dyspnea, upper abdominal discomfort, cough, chest pain, palpitation, fatigue. However, most of the patients are asymptomatic. The main purpose of treatment of chylopericardium is the prevention of cardiac tamponade and prevention of metabolic, nutritional, and immunological compromise due to chyle leak. Here, we report a case of chylopercardium secondary to lymphangiomyoma with review of the literature.

• 대한영상의학회지
• /
• 제81권6호
• /
• pp.1492-1496
• /
• 2020

장간막 혈전정맥염은 장의 허혈 및 경색을 일으킬 수 있는 드문 질환으로, 게실염이나 충수돌기염 등의 염증성 장질환으로 인해 이차적으로 발생한다. 게실 질환에 의해 발생한 장간막 혈전정맥염의 빈도는 매우 낮고 증상이 비특이적이므로 영상학적 진단이 매우 중요하다. 저자들은 61세 여성의 전산화단층촬영에서 말단 회장의 게실염에 동반된 상장간막 혈전정맥염으로 진단받고 항생제, 경구 항응고제 치료 및 우반 결장 절제술 후 혈전정맥염이 소실된 증례를 경험하여 보고한다.

• 한국정보전자통신기술학회논문지
• /
• 제15권6호
• /
• pp.463-470
• /
• 2022

정맥주사는 환자의 치료를 위해 주사 약물, 수액, 비경구 영양, 혈액제제의 투입 등에 광법위하게 이용되고 있으며 입원 환자에게 가장 빈번하게 행해지는 침습적 처치로서, 채혈, 말초 카테터 삽입 및 기타 IV요법 등에 해당하며 연간 10억건 이상 발생하고 있다. 정맥주사는 정맥주사 교육을 받은 숙련된 간호사들에 의해서만 시술되는 어려운 시술 중에 하나이며 실패 시 정맥에 혈전증 및 혈종이나 신경손상 등을 초래할 수 있다. 정맥주사를 자주 시술하는 간호사들도 비만, 피부색, 나이 등의 요인으로 정맥 검출이 쉽지 않아 실수들이 발생하는 경우도 있다. 이에 정맥주사 시 실수를 줄이기 위해 손등이나 팔의 정맥 구조를 시각화할 수 있는 보조 장비들에 대한 연구들이 발표되고 있다. 본 논문은 정맥주사 시 정맥의 구조를 시각화하는 정맥검출 장비 개발에 관한 연구에 대한 내용으로서, 정맥검출을 위한 실험 모듈을 제작하고 각기 다른 파장대를 지닌 NIR(근적외선) LED와 Filter의 파장대 조합에 따른 획득 영상의 밝기 비교를 통해 최적의 조합을 선정하는 연구를 진행했다. 또한 구현한 정맥검출 실험 모듈을 통해 획득한 정맥 영상의 선명화를 위해 그레이스케일 변환, 히스토그램 평활화, 샤프닝 필터 적용하고 이진화 이후 마킹을 통해 혈관 부분을 녹색으로 변환하는 영상처리 알고리즘을 도출하였다.

• Korean Journal of Radiology
• /
• 제23권1호
• /
• pp.68-76
• /
• 2022

Objective: Percutaneous portal vein (PV) stent placement can be an effective treatment for symptoms associated with portal hypertension. This study aimed to evaluate the effect of PV stenting on the overall survival (OS) in patients with malignant PV stenosis. Materials and Methods: Two groups of patients with malignant PV stenosis were compared in this retrospective study involving two institutions. A total of 197 patients who underwent PV stenting between November 2016 and August 2019 were established as the stent group, whereas 29 patients with PV stenosis who were treated conservatively between July 2013 and October 2016 constituted the no-stent group. OS was compared between the two groups before and after propensity score matching (PSM). Risk factors associated with OS were evaluated using the Cox proportional hazards model. Procedure-associated adverse events were also evaluated. Results: The stent group finally included 100 patients (median age, 65 [interquartile range, 58-71] years; 64 male). The no-stent group included 22 patients (69 [61-75] years, 13 male). Stent placement was successful in 95% of attempted cases, and the 1- and 2-year stent occlusion-free survival rate was 56% (95% confidence interval, 45%-69%) and 44% (32%-60%), respectively. The median stent occlusion-free survival time was 176 (interquartile range, 70-440) days. OS was significantly longer in the stent group than in the no-stent group (median 294 vs. 87 days, p < 0.001 before PSM, p = 0.011 after PSM). The 1- and 3-year OS rates before PSM were 40% and 11%, respectively, in the stent group. The 1-year OS rate after PSM was 32% and 5% in the stent and no-stent groups, respectively. Anemia requiring transfusion (n = 2) and acute thrombosis necessitating re-stenting (n = 1) occurred in three patients in the stent group within 1 week. Conclusion: Percutaneous placement of a PV stent may be effective in improving OS in patients with malignant PV stenosis.